Identification of methylation related genes from Lacer Capture Microdissected colon samples during investigation of adenoma-carcinoma sequence;Metilációs szabályozás alatt álló gének azonosítása lézerrel kimetszett vastagbéldaganat-sejtekben az adenoma-carcinoma sorrend vizsgálata során

Orvosi Hetilap

Volumn 151, Issue 20, 2010, Pages 805-814

  Spisák, Sándor ^a,b,c   Kalmár, Alexandra ^b   Galamb, Orsolya ^a,b   Sipos, Ferenc ^b   Wichmann, Barnabás ^b   Molnár, Béla ^a,b   Tulassay, Zsolt ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Semmelweis Egyetem   (Hungary)

Author keywords

Epigenetics; Gene expression pattern; Methylation regulation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; CANCER GROWTH; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; EPITHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; MARKER GENE; PROGNOSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; TUMOR SUPPRESSOR GENE;

EID: 77952229513     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28867     Document Type: Article

References (41)

1. Vogelstein, B., Fearon, E. R., Hamilton, S. R. es mtsai: Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 1988, 319, 525-532.
2. Jass, J. R.: Colorectal cancer: a multipathway disease. Crit. Rev. Oncog., 2006, 12, 273-287.
3. Grady, W. M., Markowitz, S. D.: Genetic and epigenetic alterations in colon cancer. Ann. Rev. Genomics Hum. Genet., 2002, 3, 101-128.
4. Carethers, J. M.: The cellular and molecular pathogenesis of colorectal cancer. Gastroenterol. Clin. North Am., 1996, 25, 737-754.
5. Fearon, E. R.: Genetic alterations underlying colorectal tumorigenesis. Cancer Surv., 1992, 12, 119-136.
6. Grady, W. M.: Genomic instability and colon cancer. Cancer Metastasis Rev., 2004, 23, 11-27.
7. Tang, J. T., Fang, J. Y.: MicroRNA regulatory network in human colorectal cancer. Mini Rev. Med. Chem., 2009, 9, 921-926.
8. Takayama, T., Shiozaki, H., Doki, Y. es mtsai: Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer. Br. J. Cancer, 1998, 77, 605-613.
9. Kim, Y. S.: Mucin glycoproteins in colonic neoplasia. Keio J. Med., 1998, 47, 10-18.
10. Grady, W. M.: Epigenetic events in the colorectum and in colon cancer. Biochem. Soc. Trans., 2005, 33, 684-688.
11. Dumont, N.: Genetic and epigenetic contributions to colorectal cancer. Apmis, 1999, 107, 711-722.
12. Sipos, F., Muzes, G., Valcz, G. es mtsai: Regeneration associated growth factor receptor and epithelial marker expression in lymphoid aggregates of ulcerative colitis. Scand. J. Gastroenterol., 2010, 45, 440-448.
13. Spisak, S., Galamb, B., Sipos, F. es mtsai: Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer. Dis. Markers, 2010, 28, 1-14.
14. Spisak S., Galamb B., Wichmann B. es mtsai: Vastagbeldaganatok ellenanyag-microarray-vel kimutatott TMA-validalt progresszios markerei. Orv. Hetil., 2009, 150, 1607-1613.
15. Spisak, S., Guttman, A.: Biomedical applications of protein microarrays. Curr. Med. Chem., 2009, 16, 2806-2815.
16. Spisak S., Molnar B., Galamb O. es mtsai: Feherjechipek elmeleti alapjai es alkalmazasi lehet?seguk az orvosi diagnosztikaban es kutatasban. Orv. Hetil., 2007, 148, 1511-1520.
17. Siedlecki, P., Zielenkiewicz, P.: Mammalian DNA methyltransferases. Acta Biochim. Pol., 2006, 53, 245-256.
18. Eden, S., Cedar, H.: Role of DNA methylation in the regulation of transcription. Curr. Opin. Genet. Dev., 1994, 4, 255-259.
19. Jones, P. L., Veenstra, G. J., Wade, P. A. es mtsai: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 1998, 19, 187-191.
20. Bai, A. H., Tong, J. H., To, K. F. es mtsai: Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int. J. Cancer, 2004, 112, 846-853.
21. Kurkjian, C., Kummar, S., Murgo, A. J.: DNA methylation: its role in cancer development and therapy. Curr. Probl. Cancer, 2008, 32, 187-235.
22. Ogino, S., Goel, A.: Molecular classifi cation and correlates in colorectal cancer. J. Mol. Diagn., 2008, 10, 13-27.
23. Toyota, M., Ahuja, N., Ohe-Toyota, M. es mtsai: CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 1999, 96, 8681-8686. (Pubitemid 29354851)
24. Chen, R. Z., Pettersson, U., Beard, C. es mtsai: DNA hypomethylation leads to elevated mutation rates. Nature, 1998, 395, 89-93.
25. Baylin, S. B., Herman, J. G., Graff, J. R. es mtsai: Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 1998, 72, 141-196.
26. Herman, J. G., Merlo, A., Mao, L. es mtsai: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 1995, 55, 4525-4530.
27. Garinis, G. A., Menounos, P. G., Spanakis, N. E. es mtsai: Hypermethylation- associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J. Pathol., 2002, 198, 442-1429
28. Murao, K., Kubo, Y., Ohtani, N. es mtsai: Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br. J. Dermatol., 2006, 155, 999-1005.
29. Mitomi, H., Fukui, N., Tanaka, N. es mtsai: Aberrant p16(INK4a) methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity. J. Cancer Res. Clin. Oncol., 2010, 136, 323-331.
30. Baylin, S. B., Herman, J. G.: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet., 2000, 16, 168-174.
31. Bibikova, M., Lin, Z., Zhou, L. es mtsai: High-throughput DNA methylation profi ling using universal bead arrays. Genome Res., 2006, 16, 383-393.
32. Lister, R., Pelizzola, M., Dowen, R. H. es mtsai: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 2009, 462, 315-322.
33. Zhou, D., Qiao, W., Wan, Y. es mtsai: Microarray-based methylation analysis using dual-color fl uorescence hybridization. J. Biochem. Biophys. Methods, 2006, 66, 33-43.
34. Grunau, C., Clark, S. J., Rosenthal, A.: Bisulfi te genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res., 2001, 29, E65-5.
35. Mohn, F., Weber, M., Schubeler, D. es mtsai: Methylated DNA immunoprecipitation (MeDIP). Methods Mol. Biol., 2009, 507, 55-64.
36. Xiong, Z., Laird, P. W.: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res., 1997, 25, 2532-2534.
37. Galamb, O., Spisak, S., Sipos, F. es mtsai: Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor. Br. J. Cancer, 2010, 102, 765-773.
38. Allen, N. P., Donninger, H., Vos, M. D. es mtsai: RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene, 2007, 26, 6203-6211.
39. Le Frere-Belda, M. A., Cappellen, D., Daher, A. es mtsai: p15(INK4b) in bladder carcinomas: decreased expression in superfi cial tumours. Br. J. Cancer, 2001, 85, 1515-1521.
40. Zhang, Z., Huettner, P. C., Nguyen, L. es mtsai: Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. Oncogene, 2006, 25, 5436-5445.
41. Piskurich, J. F., Youngman, K. R., Phillips, K. M. es mtsai: Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-gamma. Mol. Immunol., 1997, 34, 75-91.